Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Clinical Trials01:16

Clinical Trials

10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spontaneous remission of Merkel cell carcinoma presenting with tertiary lymphoid structures in an immunocompetent patient.

Dermatology reports·2026
Same author

Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two cases.

Lung cancer management·2025
Same author

Pathological complete response in a patient with pleural mesothelioma treated with immunotherapy: a case report.

Frontiers in oncology·2024
Same author

Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19.

Journal of virology·2022
Same author

Totally robotic soave pull-through procedure for Hirschsprung's disease: lessons learned from 11 consecutive pediatric patients.

Pediatric surgery international·2019
Same author

Deinococcus radiodurans' SRA-HNH domain containing protein Shp (Dr1533) is involved in faithful genome inheritance maintenance following DNA damage.

Biochimica et biophysica acta. General subjects·2018

Related Experiment Video

Updated: Dec 24, 2025

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

13.6K

Roneparstat: Development, Preclinical and Clinical Studies.

Alessandro Noseda1, Paola Barbieri2

  • 1Leadiant Biosciences S.p.A, Rome, Italy. alessandro.noseda@leadiantbiosciences.com.

Advances in Experimental Medicine and Biology
|April 11, 2020
PubMed
Summary
This summary is machine-generated.

Roneparstat, a potent heparanase inhibitor, shows therapeutic potential beyond Multiple Myeloma, impacting cancer and inflammatory diseases. Further research clarifies its mechanisms and guides new inhibitor development.

Keywords:
CancerFibrosisHeparanaseHeparanase inhibitorsInflammationMultiple myelomaPhase IRoneparstat

More Related Videos

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.1K
Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

4.1K

Related Experiment Videos

Last Updated: Dec 24, 2025

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
08:33

Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector

Published on: February 28, 2016

13.6K
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

18.1K
Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues
08:07

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

4.1K

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Heparanase enzyme plays a crucial role in cancer and inflammatory diseases.
  • Heparanase inhibitors are being explored for therapeutic applications.
  • Roneparstat is a well-studied, potent inhibitor of heparanase.

Purpose of the Study:

  • To provide a comprehensive overview of Roneparstat's properties and studies.
  • To discuss the therapeutic potential of Roneparstat in various conditions.
  • To explore the role of heparanase and its inhibition in disease.

Main Methods:

  • Review of existing scientific literature on Roneparstat.
  • Analysis of preclinical and clinical data.
  • Investigation of enzyme-inhibitor kinetics and molecular mechanisms.

Main Results:

  • Roneparstat demonstrates significant heparanase inhibitory activity.
  • Therapeutic potential confirmed in Multiple Myeloma and other cancers.
  • Activity observed in non-oncological conditions, aiding understanding of heparanase function.
  • Molecular mechanisms of enzyme-inhibitor interaction elucidated.

Conclusions:

  • Roneparstat is a promising therapeutic agent with broad applicability.
  • Further research into heparanase inhibition can lead to novel drug development.
  • Understanding heparanase's role is key to developing new treatments.